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Abstract
Background: Consumers are hesitant in choosing generic medications as they are under the assumption that they
are not as safe nor effective as brand medications. However, pharmacists do have the education and training to
know that this is not the case. The aim of this study was to determine pharmacists’ preference of generic versus
brand over-the-counter (OTC) medication for their personal use as self-treatment for various health symptoms.
Methods: A prospective, cross sectional study was conducted on 553 licensed pharmacists who were presumed to
have expertise in the use of generic and brand name OTC medications. In a single Southwestern state in the
United States, from December 2014 to January 2015, a web-based questionnaire was sent to pharmacists to explore
their preference of brand and generic medications based on various health symptoms. Thirty-one brand-generic
medication pairs were used to identify which medication type pharmacists preferred when asked about nine health
symptoms. Frequency counts of pharmacists’ preference of a brand medication or a generic OTC medication
overall and for each of the nine health symptoms were determined. Chi-squared analyses and one-way ANOVA
were conducted to determine if there were any differences between the preferences of brand and generic OTC
medications across each symptom.
Results: The study overall showed that pharmacists preferred generic OTC medications to brand OTC medications
(62 to 5 %, respectively). Based on an 11-point rating scale, pharmacists were likely to take OTC generic medications
(as their choice of self-treatment) when presented with health symptoms (mean = 7.32 ± 2.88). In addition, pharmacists
chose generic OTC medications over brand medications regardless of health symptoms (p < 0.001).
Conclusion: Pharmacists who have expertise in medications were shown to prefer using generic OTC medications
rather than brand name OTC medications for self-treating a variety of health symptoms. These study findings support
the theory that expertise affects preference for generic versus brand name OTC medications. This information can be
used to provide consumers the evidence needed to make well-informed choices when choosing between brand and
generic medications.
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Background
Of the many ways prescription and over-the-counter
(OTC) medications are classified, the two most common
categories are by brand and generic. In the United States
(US), the development and promotion of more generic
medications was made possible through the Hatch-
Waxman Act in 1984 [1]. Prior to this Act, the process
to develop any medication required a tedious process,
thus very few generic medications were produced by
pharmaceutical companies. The development of generic
medications has allowed consumers in the US to save a
substantial amount of money in the range of $8 to $10
billion a year at retail pharmacies and an even greater
amount at hospitals [2]. While generic medications are
considered to be cost-effective compared to their brand
name counterpart, the use of generic medications by
consumers is still lacking within the US healthcare sys-
tem [3]. Many reasons come into play when consumers
consider the use of generic medications over brand med-
ications. The primary hesitation is the idea that generic
drugs are not as safe or effective as their brand name
counterpart. Other research has indicated that even
though patients may find generic drugs to be of good
value and cost, the majority just prefer not to use them
[3]. In addition, patients believe that medications that
have been on the market longer are considered safer
than newer ones. Also, healthier patients are more con-
cerned about the efficacy of generic medications, similar
to that of older adults, who prefer brand name medica-
tion to generic medication [3].
While earlier studies have shown consumers’ preference
[4, 5] and pharmacists [6, 7] and physicians’ opinion [8] of
generic and brand medication, only one study has exam-
ined pharmacists’ actual behavior related to their personal
use of brand name versus generic drugs for self-treatment.
Using data from the 2004–2011 Nielsen Homescan panel,
a study was conducted that explored pharmacists pur-
chasing behavior for brand-name or generic OTC medica-
tions for headaches [9]. In general, there are times where
one population type may be more knowledgeable (i.e., has
more information) than another population type, thus
leading to potentially different decisions/choices for each
group due to the knowledge gap. This economics-based
theory is known as information asymmetry. This study
was based on that theoretical premise where consumer
preference for brand name OTC medications reflects
misinformation derived from advertising by companies
marketing brand name products. If consumers were
fully informed (i.e., had appropriate knowledge and
background as is assumed in information asymmetry
[10]), they would purchase less costly generic OTC
medications. The hypothesis was tested by assuming
that expertise, in this case, expertise in medications,
could serve as a proxy for perfect information and that
by observing the purchasing behavior of pharmacists,
the researchers could determine if consumers with ex-
pertise in medications behave differently than lay con-
sumers. The study showed that 91 % of pharmacists
purchased generic OTC medications for headaches
while only 74 % of consumers purchased generics [9].
The authors concluded that consumers could reduce
expenditures by $44 billion if they used store brands
whenever possible [9]. However, the study was limited
as it did not include OTC medications for other symp-
toms and the sample size was small [9].
In addition to being experts in the area of OTC medi-
cations, pharmacists offer other advantages when study-
ing the preference for brand name or generic OTC
medications. Pharmacists provide a homogeneous popu-
lation that is well educated and with a relatively high
income. Hence pharmacists’ decisions should be influ-
enced less by differences in education or income. Also,
pharmacists can be assumed to have the ability to under-
stand the items on a questionnaire and respond appro-
priately. Ability to respond accurately to questionnaires
and to understand technical language was the rationale
for recruiting nurses to the Nurses’ Health Study, a very
large longitudinal study of 238,000 nurses on the rela-
tionship between nutrition and health [11].
The objective of this study was to identify pharmacists’
preference on their personal use of brand versus generic
OTC medications used to self-treat common health con-
ditions/symptoms. Findings from this study would help
in extrapolating the results into useful evidence for when




A cross-sectional study was conducted by administering
an online questionnaire to pharmacists registered in a
single Southwestern state in the US. Qualtrics®, an online
survey generator, was used to develop and distribute the
questionnaire. Although on-line questionnaires typically
have a very low response rate, the authors considered this
type of data collection as the optimal approach to achieve
the purpose of this study, [12, 13] which was to explore
the effect of expertise on the use of generic versus brand
name OTC medications. The study followed the Declar-
ation of Helsinki in the consideration of ethics in the
research study on patients. Thus, a protocol was devel-
oped and approved by the University of Arizona Institu-
tional Review Board. Informed consent was provided
by participants prior to starting the questionnaire. The
questionnaire was made anonymous and no identifi-
able data was collected. The questionnaire was avail-
able for eight weeks, from December 2014 to January
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2015, with two follow-up reminders at the 4-week and
6-week points.
Participants
To be eligible for this study, respondents had to be reg-
istered as licensed pharmacists in a single Southwestern
state with a valid email address listed with the State
Board of Pharmacy. Pharmacy students, pharmacy in-
terns, and pharmacy technicians were not included in
the study. The State Board of Pharmacy had 7,265 regis-
tered pharmacists with email addresses during the time
of the study. Individuals could only participate in the
survey if they received a unique link via email to access
the online questionnaire.
Instrument
An original survey was developed for this study; there-
fore, the majority of questions were not derived from
any previously established questionnaires. Throughout
the development of the questionnaire, individuals who
had a Doctor of Pharmacy degree and had knowledge
about brand medications and their generic counterpart
were used to make sure the information for each ques-
tion was valid. The questionnaire contained nine health
symptoms (aches, allergies, cough, acid reflux, constipa-
tion, insomnia, daytime cold and flu, nighttime cold and
flu and pain) with 31 brand-generic medication pairs to
explore pharmacists’ preference of brand and generic
medications. In addition, a “neither” option was given
for each pair if pharmacists did not prefer either type of
medication. An example of the type of questions that
were asked can be seen in Fig. 1.
The health symptoms and their associated mediations
were derived from the 2012 American Pharmacists As-
sociation (APhA) OTC Medication Survey [14], which
asked pharmacists how many times per week they
recommended various categories of OTC medications.
From their data, common health symptoms based on
their medication categories were chosen. Medications
that were recommended at 10 % and greater for each of
the nine health symptoms were used in this study’s ques-
tionnaire so that less common medication pairs were
excluded and would allow for a more concise survey.
Topical creams, infant medications, medical equipment,
and various other uncommonly used medications were
excluded from the survey. Since the APhA study only
provided brand name medications, Medscape®, an online
resource used by health professionals for medical infor-
mation, was used to identify the generic counterparts.
In addition, the questionnaire included items that
identified cost and bioequivalency influences, health sta-
tus and general demographics. However, for this study,
the main focus was on pharmacists’ preference of brand
and generic medications based on the responses they
made on the questionnaire.
Data collection and analysis
The questionnaire consisted of the following sections: (i)
general demographics, (ii) preference of brand versus
generic OTC medications based on symptoms, (iii) influ-
ence of cost and bioequivalency on medication choice,
and (iv) health status. The questionnaire was pilot tested
with seven graduate students who had a professional
pharmacy degree, but were not registered as licensed
pharmacists in the state of Arizona. This was done to
check for correct formatting, grammar, and content, and
to make sure that the data was being collected appropri-
ately. The survey took about 10–15 min for participants
to complete, but were allowed as much time to complete
as needed and had the ability to stop and restart the sur-
vey at a later time. In addition, prior to distributing the
questionnaire, settings were established within Qualtrics®
to make sure the questionnaire was anonymous with no
identifiers (e.g., name, location, IP address) and that par-
ticipants could not respond to the questionnaire more
than once. Qualtrics® was also used to collect the re-
sponses from the questionnaire. The investigators for-
matted and coded the data to be analyzed using Stata®,
version 13. Chi-squared tests were conducted to deter-
mine if there was a significant difference between the
preference of the type of OTC medication based on
general demographic characteristics, health symptoms,
and health status. One-way ANOVA was conducted to
determine the differences in the likelihood of taking
OTC medications based on the health symptoms.
Multiple logistic regressions were conducted to deter-
mine the association of covariates with the preference
of brand and generic medications (demographic and
work-related variables).
Results
A total of 553 participants responded prior to the survey
being closed (7.6 % response rate). Throughout the sur-
vey period, 148 individuals chose to opt out from
responding to the survey. The demographic and work-
related characteristics of the study participants are pre-
sented in Table 1. The typical respondent was a 48-year-
old white, male, Doctor of Pharmacy degree holder with
a household income of greater than $150,000 who
worked full-time in a chain pharmacy as a Staff Pharma-
cist and had 21 or more years of experience.
Table 2 illustrates pharmacists’ preference of brand, gen-
eric, or neither type of medications was stratified by nine
health symptoms that correlated with the medications
used as treatment for the health symptoms. There was a
statistically significant difference between the three groups
based on health symptoms (p < 0.001). Additional analyses
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were performed on brand versus generic, brand versus
neither, and generic versus neither. The results indicated
that there were statistically significant differences be-
tween each of the group pairs based on health symp-
tom. Respondents were least likely to choose brand
name insomnia and pain medications (1.4 %), but were
more likely to choose brand name cough medications
(14.4 %). Also, respondents were less likely to choose
generic pain medications (26.3 %), but were more
likely to choose generic ache medications (81.2 %).
Overall, respondents would prefer not taking brand or
generic medications for pain (72.3 %, compared to 1.4
and 26.3 %).
In Table 3, the means of the likelihood of taking an
OTC medication for each of the nine health symptoms
are displayed. The results indicated that the health
Fig. 1 Example of survey questions asked to pharmacists for their personal treatment of aches, headaches, and fever
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symptoms elicited statistically significant differences in
the mean likelihood of taking OTC medications (p < 0.05).
In addition, based on the mean responses, pharmacists
were most likely to take OTC medications for aches, while
least likely to take medications for insomnia. While re-
spondents were likely to take OTC medications for pain
based on the mean responses (8.01), there was a contra-
diction in pharmacists’ overall preference between brand,
generic, and neither choices in that pharmacists did not
prefer any of the pain medications for the product pairs
that were provided in this survey or chose not to self-treat
this specific symptom.
The multivariate logistic regression analysis revealed a
statistically significant association between races, work
statuses, years of experiences with the use of generic
OTC medications for the treatment of pain. No other
significant relationships were identified between the use
of generic OTC medications and other demographic and
other work related variables measured in this study.
Discussion
The most important finding of this study is that pharma-
cists had an overwhelming preference for generic OTC
medications compared to brand OTC medications (62 to
5 %) for symptoms that they personally experience. Fur-
thermore, there were pharmacists that preferred to not
use the listed (brand or generic) OTC medication, but
rather may have preferred another product entirely or to
not treat the symptom. The preference for generic medi-
cation was shown overall and across all health symptom
categories. For aches, allergies, cough, acid reflux, con-
stipation, insomnia, daytime cold and flu, nighttime cold
and flu, and pain, pharmacists chose generic medications
over brand medications. Also, when presented with a
health symptom, pharmacists indicated that they were
quite likely (overall mean rating of 7.3 on a scale where
10 = very likely) to take an OTC medication for almost
all symptoms, except for insomnia (mean rating = 4.8).
An earlier study on pharmacists’ was done to identify
pharmacists’ choice of store-brand (generic) and brand
named headache and pain medication. Their results cor-
responded with this study’s findings in that pharmacists
are more informed about the active ingredients in medi-
cations, thus were more likely to choose store-brand or
generic medications than other consumers [9]. Both
Table 1 Demographic and work-related characteristics of
pharmacist participants surveyed about preference of OTC








Hispanic or Latino Origin 22 (3.98)
White 481 (86.98)
Black or African American 11 (1.99)
Native American or American Indian 2 (0.36)
Asian/Pacific Islander 43 (7.78)
Other 16 (2.89)
Household Income
Less than $99,999 62 (11.21)
$100,000–$129,000 129 (23.33)
$130,000–$150,000 102 (18.44)
More than $150,000 260 (47.02)
Primary Site of Practice
Independent Pharmacy 45 (8.14)
Chain Pharmacy 213 (38.52)
Hospital Pharmacy 107 (19.35)
Ambulatory Care Pharmacy 19 (3.44)
Managed Care Pharmacy 37 (6.69)
Long-Term Care Pharmacy 13 (2.35)
Other 119 (21.52)
Job Title
Staff Pharmacist 239 (43.22)
Clinical Pharmacist 104 (18.81)
Pharmacy Manager 125 (22.60)
Assistant Pharmacy Manager 8 (1.45)
Other 77 (13.92)
Pharmacy Professional Degree
Doctor Pharmacy 311 (56.24)




Not Employed/Retired 34 (6.15)
Years of Experience
Less than 1 Year 1 (0.18)
1–5 Years 89 (16.09)
6–10 Years 73 (13.20)
Table 1 Demographic and work-related characteristics of
pharmacist participants surveyed about preference of OTC
medications (n = 553) (Continued)
11–15 Years 62 (11.21)
16–20 Years 44 (7.96)
21+ Years 284 (51.36)
Abbreviations used: SD standard deviation
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studies demonstrated information asymmetry where the
pharmacists were more knowledgeable in the area of
pharmaceuticals compared to other consumers, thus
were able to make a well-informed decision.
The overwhelming preference for generic OTC medi-
cations found in this study are consistent with the find-
ings of Bronnenberg et al. that 91 % of pharmacists in
their sample purchased generic OTC headache medica-
tions [9]. A study of Irish pharmacists’ perceptions and
attitudes revealed that 98 % of pharmacists believed that
the quality of generics was similar to brand-name medi-
cations, however, 7 % stated that they would prefer the
original product for their personal use [15]. The 7 % of
Irish pharmacists is similar to the 5 % of pharmacists in
this sample who prefer brand name medications. How-
ever, the findings of this study may not be generalizable
to all other countries. A study in New Zealand assessed
pharmacists’ perceptions of generic medications in gen-
eral; the findings indicate that the perceptions of generic
medications were less positive than in the United States;
65 % of New Zealand pharmacists believed that brand
name medications were of higher quality than generic
medications [7].
Pharmacists who had more years of experience were
less likely to choose generic medications compared to
those who had less years of experience. This supports
previous research, which indicated that pharmacists who
had never practiced in a pharmacy setting were more
likely to understand generic medication than those who
had more years of practice [7]. This can be due to the
assumption that there is more information and educa-
tion given to pharmacy students now than in the past.
During the 1980s, pharmacists believed that making sub-
stitution decisions had great risks so they lacked the
confidence in making generic substitutions. In addition,
they lacked the confidence in the quality and therapeutic
effects compared to brand medications [16]. Thus, this
research study shows that individuals who have had ten
years of experience or less from this time point were
more likely to prefer generic medications compared to
those who had eleven years or more of experience. Pre-
vious studies indicated that pharmacists were hesitant to
suggest generic medications due to risks, especially
based on the extent of the medical condition of the pa-
tient [17]. However, education has changed throughout
the years and laws have been implemented, which has
required pharmacists to dispense generics appropriately
and has allowed them to gain more knowledge about
generic medications to feel comfortable in substituting
them for brand medications [18].
Also, from the results, it can be seen that pharmacists
prefer generic medications (n = 9146) versus brand medi-
cations (n = 740) or neither types of medication (n =
4958). This was based on the counts of each pair of medi-
cations for the nine different health symptoms. In almost
all symptoms, except insomnia, the preference of generic
medication was far greater than brand medication, while
Table 2 Pharmacists’ preference of brand, generic, or neither type of OTC medication by type of health symptoms
Brand Generic Neither Total p-value*
Aches 61 (4.02 %) 1233 (81.2 %) 225 (14.8 %) 1519 <0.001
Allergies 59 (2.4 %) 1941 (77.6 %) 503 (20.1 %) 2503 <0.001
Acid Reflux 173 (5.8 %) 1875 (62.4 %) 957 (31.9 %) 3005 <0.001
Constipation 163 (7.1 %) 1273 (55.6 %) 852 (37.2 %) 2288 <0.001
Cough 148 (14.4 %) 687 (66.6 %) 196 (19.0 %) 1031 <0.001
Pain 29 (1.4 %) 544 (26.3 %) 921 (72.3 %) 1494 <0.001
Insomnia 14 (1.4 %) 561 (55.1 %) 444 (43.6 %) 1019 <0.001
Nighttime Cold and Flu 52 (5.3 %) 536 (54.3 %) 399 (40.4 %) 987 <0.001
Daytime Cold and Flu 41 (4.1 %) 496 (49.7 %) 461 (46.2 %) 998 <0.001
Total 740 (5.0 %) 9146 (61.6 %) 4958 (33.4 %) 14844a
*Chi-squared test for all comparisons
aTotal responses for all 31 product pairs across 9 symptoms
Table 3 Pharmacists’ responses for the likelihood of taking OTC
medications by health symptoms




Nighttime Cold and Flu 7.60 (2.92)
Acid Reflux 7.42 (2.97)




Average of Mean Responses 7.32 (2.88)
Abbreviations used: SD standard deviation
aFrom an 11-point Likert Scale, where 0 = Not Likely and 10 = Very Likely
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in insomnia; pharmacists preferred the option of neither
brand nor generic medication. This may have been due to
the fact that insomnia is not as common of a symptom
compared to the other health symptoms that were used in
this study. Pharmacists’ preference of generic medications
can be attributed to their knowledge in the area of phar-
macy. They are knowledgeable from the degrees they have
attained, doctor of pharmacy (n = 311) and bachelors of
pharmacy (n = 242), thus they are able to make an in-
formed choice on what medications they want to take
themselves.
Because pharmacists have relatively high incomes, it
can be assumed that pharmacists were not selecting gen-
eric OTC medications because they cannot afford brand
name OTC medications. However, use of generic OTC
medications can result in significant savings to the con-
sumer. Bronnenberg et al., 2013 estimated that total ex-
penditures for headache remedies would decrease by 13
% if consumers were as knowledgeable as pharmacists
[9]. This further supports that pharmacists have confi-
dence in generic medications and will choose them, re-
gardless of the price and their ability to afford both
types of medications.
It is not clear what the implications of pharmacists’
overwhelming preference for generic OTC medications
are for the consumer. Several studies have shown that
how health care professionals care for themselves is not
necessarily related to how they care for patients. In a
study of pharmacists’ use of skin cancer prevention
strategies, personal use of strategies to prevent sunburn
were not correlated to pharmacists’ counseling of pa-
tients about prevention strategies [19]. Incongruence be-
tween personal behaviors and patient related behaviors
suggests that factors other than personal practice (e.g.,
expectation of counseling) have a strong influence on
professional behaviors. Several studies have shown that
physicians treat themselves differently than they treat
patients. One study examined the rate of C-sections in
women physicians and found that women physicians
were 10 % less likely to have a C-section than other
women. They attributed the difference to women physi-
cians’ expertise in medical care [20]. In a second study
of the health-related behaviors of women physicians, the
authors found that women physicians’ health-related be-
haviors exceeded the goals of Healthy People 2000 [21].
The influence of the study findings on consumer be-
havior is not apparent at this time point. At least one
study has shown that informing consumers that the active
ingredients are similar does not affect their choice of gen-
eric medications [22]. Another study showed that women
who had Medicaid insurance believed that generics were
less expensive (98 %) and a better value (82 %) but only
45 % preferred to take generics themselves [23]. Perhaps
for the lay consumer, a non-scientific argument would
have more effect. For example, rather than presenting sci-
entific information, discuss how pharmacists themselves
or their family members prefer to take generic OTC
medications.
Limitations
This study has several limitations and hence interpreta-
tions should be drawn with caution keeping the following
limitations in mind. First, the sample was of pharmacists
that were licensed in a single Southwestern state, therefore
the study results do not report the prevalence of use of
generic OTC medications versus brand name OTC medi-
cations for all pharmacists. Also, due to time constraints,
the online survey was only available for two months, thus
if more time was allotted, more participants may have
provided responses. In addition, the listed medications for
each health symptom were not comprehensive of all pos-
sible medications, but rather those that were commonly
used. The use of an “Other” text box may have been bene-
ficial in this case to attain all possible responses from the
pharmacists. Lastly, the questions in the survey asked par-
ticipants about their preference of taking brand or generic
OTC medications versus their actual behavior.
Conclusion
The findings of this study indicated that pharmacists had
a significant preference for choosing generic medications
versus brand medications across the health symptoms of
aches, allergies, cough, acid reflux, constipation, insomnia,
daytime cold and flu, nighttime cold and flu and pain.
Overall, the study provided evidence that pharmacists
(experts) prefer generic medication over brand medication
for their personal use as self-treatment, supporting the
theory that experts have the information to make well-
informed decisions. Future research can be conducted on
the families of pharmacists to see what the pharmacists
recommend to the family members as treatment options.
In addition, research can be done on pharmacists’ choice
of brand and generic OTC medications for use when
treating their own children. Also, other health symptoms
and medication types (e.g., topical treatment) besides the
ones used in this study can be further researched.
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